Triple
T15983051
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Juno Therapeutics |
E387620
|
entity |
| Predicate | collaboratesWith |
P37
|
FINISHED |
| Object | Celgene |
E1188116
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Celgene | Statement: [Juno Therapeutics, collaboratesWith, Celgene]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Celgene Context triple: [Juno Therapeutics, collaboratesWith, Celgene]
-
A.
Celgene
chosen
Celgene is a biopharmaceutical company known for developing innovative therapies for cancer and inflammatory disorders.
-
B.
Janssen Pharmaceuticals
Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.
-
C.
Janssen Biotech
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
-
D.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
-
E.
Amgen
Amgen is a leading American biopharmaceutical company known for developing innovative therapies in areas such as oncology, nephrology, and inflammatory diseases.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d86da94ccc819083d187f5dc6a123e |
completed | April 10, 2026, 3:25 a.m. |
| NER | Named-entity recognition | batch_69e15756d6488190ac35da00e96ce21d |
completed | April 16, 2026, 9:40 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ffdbc8a8a081908ac1b431f524d650 |
completed | May 10, 2026, 1:13 a.m. |
Created at: April 10, 2026, 4:54 a.m.